Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Price 1368.75 INR/ Number

Get a Price/Quote

Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet Specification

Brand Name
GLIMLASE-PG2

Life Span
24 Month

Salt Composition
Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Packaging Type
10*15 Blister

Drug Type
Other

Ingredients
Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustained-release metformin (hepatic glucose suppression), pioglitazone (PPAR- agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management. Triple therapy targets insulin resistance, beta-cell dysfunction, and hepatic gluconeogenesis, achieving HbA1c reductions of 2.2-2.8% in patients uncontrolled on dual therapy; pioglitazone provides additional benefits in dyslipidemia (TG 15%, HDL 10%) and atherosclerosis regression. Adults: 1 tablet once daily with meals; side effects include hypoglycemia (15-20%), weight gain/edema (pioglitazone), GI upset (less with SR), HF risk (monitor NYHA Class I/II only); contraindicated in DKA, eGFR<30, bladder cancer history; check LFTs, echo periodically.

Physical Form
Tablets

Quantity
1 Strip

Storage Instructions
cool & dry place

Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet Trade Information

Minimum Order Quantity
100 Number

Delivery Time
5 Days

About Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustained-release metformin (hepatic glucose suppression), pioglitazone (PPAR- agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management.

Tell us about your requirement